Tag Archives: Lupus Nephritis

August, 2016

March, 2016

  • 2 March

    Aurinia’s Lupus Nephritis Drug Awarded FDA Fast Track Designation

    VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for voclosporin, the Company’s next generation calcineurin inhibitor, for the treatment of Lupus Nephritis (LN). The Fast Track program was created by …